ISC, DOAJ, CAS, Google Scholar......

Document Type : Meta - Analysis

Author

Department of pathology, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran

Abstract

In this article we Investigate the Effects of Chemical Drugs on Clinicopathological and Survival in Hepatocellular Carcinoma. Hepatocellular carcinoma (primary liver cancer) arises from liver cells and is different from secondary liver cancer, which originates from other parts of the body and spreads to the liver. Hepatocellular carcinoma is classified in different ways. A classification is made by the Barcelona Clinic Liver Cancer Group (BCLC), which classifies cancer based on how long a person is expected to live. This classification depends largely on the size of the cancer, the number of cancers in the liver, how well the liver is functioning, and whether the person's activities are affected by the cancer. Patients with intermediate-stage hepatocellular carcinoma have large and multiple cancers, but they do not have complete liver failure. The cancer is confined to the liver, and there is no limitation in the patient's daily activities. There is considerable uncertainty in the management and treatment of patients with intermediate stage hepatocellular carcinoma. Apart from using standard Cochrane methods that allow comparison of only two treatments at a time (direct comparison), planned to use an advanced method that allows comparison of many different treatments that are compared separately in trials (meta-analysis). An increase in liver enzymes can be a sign of inflammation or destruction of cells in the liver. Inflamed or damaged liver cells release larger amounts of certain chemicals, including liver enzymes, into the bloodstream, which can lead to increased liver enzymes in blood tests.

Keywords

Main Subjects

[1]. S. Golalipour, Z. Soleimanydarinsoo, N. Qaderi, H. Ghazipoor, M. Salahi, Neuro-Quantology 20
(8), 1519 (2022)
[2]. R. Monirifard, M. Abolhasani, B. Tahani, A. Fathi, A.Choobdaran, Journal of Iranian Dental
Association. 31(4):182 (2019)
[3]. R. Alimoradzadeh, N. Moosavi, A. Karimkoshteh, Z. Sadeghi, MM. Fard, A. Ismaili, Chemical
Methodologies 6(3):166 (2022)
[4]. MB. Abhari, PF. Afshar, R. Alimoradzadeh, H. Mirmiranpour., Immunopathologia Persa 6(1):
e10 (2019)
[5]. M.Mehrabanian, UZ. Ahari, A. Fathi, MM.Parizi, Clinical Schizophrenia & Related Psychoses.
15(2) (2021)
[6]. M. Jafari, A. Samimi, O. Mayeli, Journal of Applied Researches in Technical and Engineering.,
2 (7):247 (2018)
[7]. M. Bagheri Sadr, A. Samimi, Advanced Journal of Chemistry, Section B: Natural Products and
Medical Chemistry, 4(3): 174 (2022)
[8]. M. Abolhasani, P. Givehchian, A. Fathi, S. Goudarzi, Journal of Iranian Dental Association,
33(1):17 (2021)
[9]. M. Abolhasani, E. Ghasemi, AH. Fathi, MJ. Hayatizadeh. Journal of Iranian Dental Association,
33(3):51 (2021)
[10]. H. Mirjalili, H. Amani, A. Ismaili, MM. Fard, A. Abdolrazaghnejad, Journal of Medicinal and
Chemical Sciences 5(2):204 (2022)
[11]. H. Mirfakhraee, S. Golalipour, F. Ensafi, A. Ensafi, S. Hajisadeghi, Neuro-Quantology 20 (6),
5118 (2022)
[12]. H. Mir Jalili, H. Amani, A. Ismaili, MM. Fard, A. Abdolrazaghnejad, Journal of Medicinal and
Chemical Sciences 5 (2): 204 (2020)
[13]. H. Jahandideh, A. Yarahmadi, S. Rajaieh, AO. Shirazi, M. Milanifard, et al. J Pharm Ree Int,
31(6): 1 (2020)
[14]. F. Zabihi, MA. Abbasi, R. Alimoradzadeh., Annals of the Romanian Society for Cell Biology,
2573 (2021)
[15]. F. Tosan, N. Rahnama, D. Sakhaei, AH. Fathi, A. Yari, Nanomedicine Research Journal. 6(4):327
(2021)
[16]. F. Rebout, A. Samimi, Progress in Chemical and Biochemical Research 5(2): 196 (2022)
[17]. F. Afkar, S. Golalipour, M. Akanchi, SM. Sajedi, A. Zandi Qashghaie, NeuroQuantology 20 (8),
632 (2022)
[18]. E. Ghasemi, AH. Fathi, S. Parvizinia, Journal of Iranian Dental Association. 31(3): 169 (2019)
[19]. B. Mahmoodiyeh, S. Etemadi, A. Kamali, S. Rajabi, M. Milanifard, Annals of the Romanian
Society for Cell Biology, 2559 (2021)
[20]. B. Mahmoodiyeh, H. Taleby, S. Etemadi, M. Saleh Sadri, A. Susanabadi, MM. Fard, Journal of
Chemical Reviews 3(3): 219 (2021)
[21]. AO. Shirazi, H. Jahandideh, A. Yarahmadi, M. Milanifard, MM. Delarestaghi, Medical Science
24(104):2467 (2020)
[22]. AH. Fathi, SS. Aryanezhad, E. Mostajeran, UZ. Ahari, SM. Asadinejad, The Iranian Journal of
Obstetrics, Gynecology and Infertility. 25(2): 90 (2022)
[23]. A. Yarahmadi, K. Kamrava, A. Shafee, M. Milanifard, M. Aghajanpour, et al., J Pharm Res Int,
1 (2019)
[24]. A. Susanabadi, M. Saleh Sadri, H. Taleby, S. Etemadi, B. Mahmoodiyeh, M. Milani Fard, Annals
of the Romanian Society for Cell Biology 25(6):2703 (2021)
[25]. M. Abolhasani, E. Ghasemi, AH. Fathi, MJ. Hayatizadeh. Journal of Iranian Dental Association.
33(3):51 (2021)
[26]. M. Abolhasani, P. Givehchian, A. Fathi, S. Goudarzi. Journal of Iranian Dental Association.
33(1):17 (2021)
[27]. A. Aminian, A. Fathi, MH. Gerami, M. Arsan, A. Forutan Mirhosseini, Nanomedicine Research
Journal. 7(2):107 (2022)
[28]. B. Ebadian, A. Fathi, S. Khodadad. International Journal of Dentistry. 2021:1 (2021)
[29]. A. Fathi, B. Ebadian, SN. Dezaki, N. Mardasi, R. Mosharraf, S. Isler, SS. Tabatabaei.
International Journal of Dentistry. 2022:1 (2022)
[30]. AH. Fathi, SS. Aryanezhad, E. Mostajeran, UZ. Ahari, SM. Asadinejad. The Iranian Journal of
Obstetrics, Gynecology and Infertility. 25(2):90 (2022)
[31]. E. Ghasemi, AH. Fathi, S. Parvizinia. Journal of Iranian Dental Association. 31(3):169 (2019)
[32]. M. Mehrabanian, UZ. Ahari, A. Fathi, MM. Parizi. Clinical Schizophrenia & Related Psychoses.
15(2) (2021)
[33]. NCZ. Moghadam, A. Fathi, A. Salehi, MB. Rad. Academic Journal of Health Sciences. 37(4):21
(2022)
[34]. R. Monirifard, M. Abolhasani, B. Tahani, A. Fathi, A. Choobdaran. Journal of Iranian Dental
Association. 31(4):182 (2019)
[35]. F. Tosan, N. Rahnama, D. Sakhaei, AH. Fathi, A. Yari. Nanomedicine Research Journal. 6(4):327
(2021)
[36]. AH. Fathi, SS. Aryanezhad, E. Mostajeran, U. Zamani Ahari, SM. Asadinejad. Iraninan Journal
of Obstetrics, gynecology and ibfertility. 35(2):90 (2022)
[37]. SZ. Nahardani, MR. Salami, Z. Mirmoghtadaie, MH. Keshavarzi, Shiraz E-Medical Journal,
23(4): 2022
[38]. SZ. Nahardani, The Journal of Medical Education and Development, 15 (1):40 (2020)
[39]. Z. Sohrabi, H.R Koohestani, SZ. Nahardani, MH. Keshavarzi, Data in brief 21:1325 (2018)
[40]. S. Alizadeh, SZ. Nahardani, Z. Sohrabi, M. Doorfard, Iranian Journal of Medical Education 15:
656 (2015)
[41]. Z. Nahardani, Iran J Med Educ 15: 51 (2015)